Munir Essiz
Bristol-Myers Squibb
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Munir Essiz.
Journal of Medicinal Chemistry | 1989
Daniel Bouzard; P. Di Cesare; Munir Essiz; Jean-Pierre Jacquet; Philippe Remuzon; Abraham Weber; T. Oki; M. Masuyoshi
A number of 7-substituted-1-tert-butyl-6-fluoroquinolone-3-carboxylic acids and 7-substituted-1-tert-butyl-6-fluoro-1,8-naphthyridine-3-carboxylic acids have been prepared and tested for antibacterial activities. Among those the 7-aminopyrrolidinyl 20b and the 7-diazabicyclo naphthyridine 18b are the most potent compounds in vitro and in vivo. Physicochemical data and acute toxicity are also discussed. Compound 18b, BMY 40062, exhibits the most favorable overall properties, considering in vitro and in vivo microbiological activity, its low toxicity, and pharmacokinetic profile, and was selected for clinical evaluation.
Tetrahedron-asymmetry | 1997
Pascale Moreau; Munir Essiz; Jean-Yves Mérour; Daniel Bouzard
Abstract An efficient and enantiospecific synthesis of substituted 1,2-diphenylethylamines 5 from benzaldehydes is described using a recyclable chiral auxiliary.
Tetrahedron | 1995
Philippe Remuzon; Daniel Bouzard; Pierre Dicesare; Munir Essiz; Jean-Pierre Jacquet; Andrei Nicolau; Alain Martel; Marcel Menard; Carol Bachand
Abstract An efficient and stereocontrolled preparation of the key a/etidinone-acid 5a is described.
Tetrahedron Letters | 1988
Daniel Bouzard; P. Di Cesare; Munir Essiz; Jean-Pierre Jacquet; Philippe Remuzon
Resume It has been found that the Bu4NF/THF base/solvent couple is very efficient in the key cyclisation step of ( 2 ) to ( 5 ) in the synthesis of antibacterial pyridonecarboxylic acid derivatives. In particular chiral intermediate ( 2d ) is directly converted in one step to ( 4d ), a key intermediate in the synthesis of (S)-Ofloxacin.
Journal of Medicinal Chemistry | 1992
Daniel Bouzard; P. Di Cesare; Munir Essiz; Jean-Pierre Jacquet; B. Ledoussal; Philippe Remuzon; R. E. Kessler; Joan Fung-Tomc
Archive | 1987
Cesare Pierre Di; Jean-Pierre Jacquet; Munir Essiz; Philippe Remuzon; Daniel Bouzard; Abraham Weber
Journal of Medicinal Chemistry | 1991
Philippe Remuzon; Daniel Bouzard; P. Di Cesare; Munir Essiz; Jean-Pierre Jacquet; J. R. Kiechel; B. Ledoussal; R. E. Kessler; Joan Fung-Tomc
Journal of Medicinal Chemistry | 1992
P. Di Cesare; Daniel Bouzard; Munir Essiz; Jean-Pierre Jacquet; B. Ledoussal; J. R. Kiechel; Philippe Remuzon; R. E. Kessler; Joan Fung-Tomc; J. Desiderio
Archive | 1988
Abraham Weber; Daniel Bouzard; Munir Essiz; Pierre Di Cesare; Jean-Pierre Jacquet; Philippe Remuzon
Archive | 1988
Abraham Weber; Daniel Bouzard; Munir Essiz; Pierre Di Cesare; Jean-Pierre Jacquet; Philippe Remuzon